Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience

Authors:

Abstract
No abstract available

This publication has 16 references indexed in Scilit: